Niche-based screening identifies small-molecule inhibitors of leukemia stem cells

Kimberly A. Hartwell(Whitehead Institute for Biomedical Research), Todd R. Golub(Broad Institute), Shrikanta Chattopadhyay(Broad Institute), Marcus Järås(Lund University), Thomas Kindler(German Cancer Research Center), Vlado Dančík, Sebastian Shterental(Brigham and Women's Hospital), Paul A. Clemons(Broad Institute), Fátima Al‐Shahrour(Broad Institute), Mingji Dai(Purdue University West Lafayette), David J. Logan(Pfizer (United States)), Stuart L. Schreiber(Broad Institute), J. Erika Haydu(Brigham and Women's Hospital), Alison L. Stewart(Broad Institute), Rishi V. Puram(Brigham and Women's Hospital), Mildred Duvet(Broad Institute), Thomas P. Hasaka, Anne E. Carpenter(Broad Institute), Joshua A. Bittker, Christina Huang(Broad Institute), Joseph Negri(Broad Institute), Benjamin L. Ebert(Dana-Farber Cancer Institute), Nicola Tolliday(Broad Institute), Alykhan F. Shamji, Siddhartha Mukherjee(NewYork–Presbyterian Hospital), Zuzana Tóthová(Broad Institute), David T. Scadden(Harvard University), Andrew M. Stern(University of Pittsburgh), Peter G. Miller(Broad Institute), David P. Steensma(Harvard University), Alissa R. Kahn(Memorial Sloan Kettering Cancer Center), Malcolm A.S. Moore(Memorial Sloan Kettering Cancer Center), Benito Muñoz(Broad Institute), Jae Hung Shieh(Memorial Sloan Kettering Cancer Center), Rajiv Narayan(Broad Institute), D. Gary Gilliland(Brigham and Women's Hospital), Lisa P. Chu(Brigham and Women's Hospital)
Nature Chemical Biology
October 27, 2013
Cited by 110


Related Papers